Filing Details
- Accession Number:
- 0001110803-13-000383
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-25 18:49:38
- Reporting Period:
- 2013-11-21
- Filing Date:
- 2013-11-25
- Accepted Time:
- 2013-11-25 18:49:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1263805 | O Christian Henry | 5200 Illumina Way San Diego CA 92122 | Sr Vp, General Manager Genomic | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-21 | 6,000 | $28.45 | 36,236 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-11-21 | 1,200 | $93.46 | 35,036 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-11-21 | 3,200 | $94.55 | 31,836 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-11-21 | 1,300 | $95.67 | 30,536 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-11-21 | 300 | $96.38 | 30,236 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-11-21 | 6,000 | $0.00 | 6,000 | $28.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
27,000 | 2009-02-28 | 2019-01-28 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sales price representing 1,200 shares sold ranging from $92.85 to $93.78 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sales price representing 3,200 shares sold ranging from $94.05 to $95.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sales price representing 1,300 shares sold ranging from $95.34 to $96.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.